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Summary
We have previously described a statistical model capable of
distinguishing young (age <65 years) from old (age  75 years)
individuals. Here we studied the performance of a modified
model in three populations and determined whether individuals
predicted to be biologically younger than their chronological age
had biochemical and functional measures consistent with a
younger biological age. Those with ‘younger’ gene expression
patterns demonstrated higher muscle strength and serum albu-
min, and lower interleukin-6 and blood urea concentrations
relative to ‘biologically older’ individuals (odds ratios 2.09, 1.64,
0.74, 0.74; P = 2.4 3 10−2, 3.5 3 10−4, 1.8 3 10−2, 1.5 3 10−2,
respectively). We conclude that our expression signature of age
is robust across three populations and may have utility for
estimation of biological age.
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Although the importance of a healthy and active lifestyle in
promoting good health during aging is well understood (van den
Brandt, 2011), the physiological processes that influence biological
rather than chronological aging are not clear. Identification of
biomarkers for biological aging could provide a key insight into the
heterogeneity of age-related decline in function, but have been an
evasive goal. Recently, gene expression analyses have shown
promise as a new tool to measure physiological age and identify a
physical marker of aging (Weindruch et al., 2002). We previously
carried out a transcriptome-wide gene expression analysis in human
peripheral blood leukocyte samples, to determine which transcripts
were most associated with advancing age in the InCHIANTI study, a
large well-characterized population-representative cohort aged 30–
104 years (Ferrucci et al., 2000). We found that large-scale differ-
ences in transcript expression levels occurred for only a small,
focused set of genes, and that using the expression levels of only six
of these (LRRN3, CD27, GRAP, CCR6, VAMP5 and CD248), we could
distinguish between younger (age <65 years) and older subjects
(age  75 years) with high accuracy (Harries et al., 2011).
In this new study, we aimed to validate a modified InCHIANTI
marker set in two independent cohorts and test whether expression
marker-based prediction of age in the original InCHIANTI data could
identify people who were ‘biologically younger’ than their chrono-
logical age. To validate our marker set, we used blood leukocyte
samples from the Exeter-10000 study (http://www.peninsulacrf.org/
node/155) and isolated lymphocyte-derived Affymetrix expression
array data from the San Antonio Family Heart Study (SAFHS) (Goring
et al., 2007). Cohort characteristics are given in supplementary
table 1 online. Expression data on five of the six original transcripts
were available in all three populations (LRRN3, GRAP, CCR6,
VAMP5, and CD27). Three of these (LRRN3, CCR6, and CD27) were
significantly associated with age by quantitative real-time PCR in
n = 95 samples from the Exeter 10000 population and five were
significantly associated with age (P < 0.05) in SAFHS data
(n = 1,238) (supplementary table 2 online). Using the expression
levels of these five transcripts in fitted multivariable logistic
regression models distinguishing younger (age <65 years) from
older (age  75 years) and subjects in the InCHIANTI and SAFHS
cohorts produced Receiver Operating Characteristic (ROC) curves
with Area Under the Curve (AUC) values of 94% and 87%,
respectively (supplementary figure S1). We were unable to fit a ROC
curve with these age cut-offs in the Exeter 10000 data, as only three
individuals in this sample were aged  75 years, although a curve
with cut-offs of  60 vs. <60 was feasible. To assess the validity of
applying these amended cut-offs of  60 vs. <60 in the Exeter
10000 data, we first fitted ROC curves using these modified cut
points in the two larger populations. We found that the choice of
age cut-off had little effect, with ROC curves with Area Under the
Curve (AUC) values of 92% and 82% being obtained in InCHIANTI
and SAFHS cohorts, respectively (supplementary figure 2). Applying
the modified cut-off in the Exeter 10000 data, we obtained an AUC
value of 73% (supplementary figure 2). This suggests that our five-
transcript expression panel is robust across populations, despite
differences in cohort characteristics, white cell subsets, sample
handing and analytical approach, and that the model is robust
across two different age categories.
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To compare biological and chronological age in the InCHIANTI
respondents, we used a linear regression model to estimate each
individual’s age based on the five-expression transcript intensities,
with continuous age as the outcome. A total of 131 individuals were
classified as ‘biologically younger’ if, in a regression model of the
five transcripts, their predicted age was >8.5 years younger than
their actual chronological age (corresponding to 20% of the
sample). To explore associations with clinical markers of aging we
included only those aged  65 years, as clinical aging markers such
as the Short Physical Performance Battery (SPPB) are validated
mainly in such older groups (Guralnik et al., 1994; Freire et al.,
2012). This group was then analyzed for biomarkers of biological
aging including C-reactive protein (CRP), Short Physical Performance
Battery (SPPB) scores, muscle strength, interleukin-6 (IL-6) serum
levels, systolic blood pressure, hematocrit, serum albumin, and
blood urea level, which are known physiological markers of aging
(Studenski et al., 2003; Nakamura & Miyao, 2007).
We determined that four of these eight parameters (IL-6, muscle
strength, blood urea, and serum albumin) displayed a statistically
significant difference between the biologically young outliers
(n = 131) and the rest of the cohort  65 years (n = 406) (Odds
Ratios: 0.74, 2.09, 0.74, 1.64; P-values: 1.8 9 102, 2.4 9 102,
1.5 9 102, 3.5 9 104, respectively) (Fig. 1). Muscle strength
decreases with age and predicts mobility disability in older adults
(Bean et al., 2003), accordingly muscle strength was significantly
higher in the ‘biologically young’ group. IL-6 is an inflammatory
marker (Cesari et al., 2004) and serum concentrations rise with
advancing age: significantly lower levels of IL-6 were found in the
‘biological young’ group. Individuals who were predicted to be
younger than their actual age demonstrated higher serum albumin
and lower blood urea nitrogen levels. Serum albumin decreases with
age (Liu et al., 2012) and is associated with increased morbidity,
mortality, and disability in older people (Baumgartner et al., 1996).
In particular, low blood albumin is associated with reduced muscle
mass and may be indicative of sarcopenia in elderly individuals
(Visser et al., 2005). Blood urea nitrogen levels increase with age
(Aono et al., 1994) and may represent reduced kidney function. The
lower levels in ‘biologically young’ individuals may indicate better
renal performance. Systolic blood pressure, SPPB scores, CRP, and
hematocrit did not differ significantly between the ‘biologically
young’ and the remaining population, but this is probably due to the
increased variability of these parameters and a lack of statistical
power. These data indicate that individuals who have gene
expression signatures characteristic of a younger age group also
have some biochemical or functional features consistent with a
younger age and we conclude that our bi-class discriminative model
may therefore be capable of estimating biological, rather than
chronological age, and may hold utility in the future to predict
individuals who may age badly.
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Fig. 1 ROC curves with cutoff points of <65 vs. 75. ROC curves with Area
Under the Curve (AUC) for InCHIANTI and SAFHS populations with age cut
off points of younger subjects <65 and older subjects 75. AUC values were
94% and 87% for the InCHIANTI (A) and SAFHS (B) populations respectively.
Fig. 2 ROC curves with Area Under the Curve (AUC) for InCHIANTI, SAFHS
and Exeter 10000 populations with age cut off points of younger subjects
<60 and older subjects 60. AUC values were 92%, 82% and 73% for the
InCHIANTI (A), SAFHS (B) and Exeter 10000 (C) populations respectively.
Data S1 Experimental procedures.
Table S1 Characteristics of the InCHIANTI, SAHFS and Exeter 10000 cohorts.
N refers to the number of individuals in the sample. % refers to the
percentage that the figure represents of the total cohort. SD refers to the
Standard deviation of the measurement for waist circumference. n/a = data
not available.
Table S2 Genes included in the bi-class discriminant model of age in the
InCHIANTI, SAFHS and Exeter 10000 cohorts. Genes included in the bi-class
discriminant model are given below. The q-value refers to the significance
adjusted for false discovery rate (FDR). 95% CI refers to the confidence
intervals for the TLDA analysis. B = coefficient (change in standard deviations
of expression per year of age).
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